Development and characterization of a simian virus 40 immortalized bovine endometrial stromal cell line.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 18772234)

Published in Endocrinology on September 04, 2008

Authors

Narayanan Krishnaswamy1, Pierre Chapdelaine, Jacques P Tremblay, Michel A Fortier

Author Affiliations

1: Centre Hospitalier Universitaire de Québec, Centre Hospitalier de l'Université Laval, Université Laval, Québec, Canada.

Articles by these authors

Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther (2007) 3.69

Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther (2011) 2.06

Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients. Mol Ther (2013) 1.63

Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol (2006) 1.37

First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up. Neuromuscul Disord (2006) 1.37

Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation. Mol Ther (2012) 1.33

Transcription activator-like effector proteins induce the expression of the frataxin gene. Hum Gene Ther (2012) 1.31

Exercise improves the success of myoblast transplantation in mdx mice. Neuromuscul Disord (2006) 1.19

Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther (2004) 1.17

Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Mol Ther (2013) 1.16

Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts. Mol Ther (2004) 1.15

Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cells. Mol Ther (2010) 1.13

Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms. J Neuropathol Exp Neurol (2003) 1.13

Myoblast transplantation: the current status of a potential therapeutic tool for myopathies. J Muscle Res Cell Motil (2003) 1.10

Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins. Biochem Biophys Res Commun (2004) 1.08

Decidualization and maintenance of a functional prostaglandin system in human endometrial cell lines following transformation with SV40 large T antigen. Mol Hum Reprod (2006) 1.04

An aldose reductase with 20 alpha-hydroxysteroid dehydrogenase activity is most likely the enzyme responsible for the production of prostaglandin f2 alpha in the bovine endometrium. J Biol Chem (2003) 1.03

Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy. Pediatr Transplant (2010) 1.03

RCAS1 is associated with ductal breast cancer progression. Biochem Biophys Res Commun (2002) 0.99

Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy. Mol Ther (2010) 0.98

Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice. Cell Transplant (2008) 0.98

Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans. Exp Neurol (2002) 0.98

Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: implications for cell-transplantation strategies. Transplantation (2007) 0.95

Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models. Mol Ther (2007) 0.94

Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal. Transplantation (2005) 0.93

Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model. J Cell Biol (2003) 0.92

Endonucleases: tools to correct the dystrophin gene. J Gene Med (2011) 0.92

Expression of cyclooxygenases 1 and 2 and prostaglandin E synthase in bovine endometrial tissue during the estrous cycle. Biol Reprod (2002) 0.92

Molecular cloning and spatio-temporal expression of the prostaglandin transporter: a basis for the action of prostaglandins in the bovine reproductive system. Proc Natl Acad Sci U S A (2003) 0.90

The paracrine effect: pivotal mechanism in cell-based cardiac repair. J Cardiovasc Transl Res (2010) 0.90

Dystrophin expression following the transplantation of normal muscle precursor cells protects mdx muscle from contraction-induced damage. Cell Transplant (2010) 0.90

The Prostaglandin F Synthase Activity of the Human Aldose Reductase AKR1B1 Brings New Lenses to Look at Pathologic Conditions. Front Pharmacol (2012) 0.90

Intramuscular cell transplantation as a potential treatment of myopathies: clinical and preclinical relevant data. Expert Opin Biol Ther (2011) 0.90

Intramuscular transplantation of myogenic cells in primates: importance of needle size, cell number, and injection volume. Cell Transplant (2013) 0.89

A Potential New Therapeutic Approach for Friedreich Ataxia: Induction of Frataxin Expression With TALE Proteins. Mol Ther Nucleic Acids (2013) 0.89

Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into MDX skeletal muscle. PLoS One (2012) 0.89

Aldose reductase and macrophage migration inhibitory factor are associated with epididymosomes and spermatozoa in the bovine epididymis. Biol Reprod (2003) 0.86

Dynamics of the early immune cellular reactions after myogenic cell transplantation. Cell Transplant (2002) 0.86

Expression of dog microdystrophin in mouse and dog muscles by gene therapy. Mol Ther (2010) 0.86

Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice. Transplantation (2004) 0.86

Differential expression of the enzymatic system controlling synthesis, metabolism, and transport of PGF2 alpha in human fetal membranes. Biol Reprod (2010) 0.85

Treatment with anti-CD154 antibody and donor-specific transfusion prevents acute rejection of myoblast transplantation. Transplantation (2002) 0.85

Transplanted myoblasts can migrate several millimeters to fuse with damaged myofibers in nonhuman primate skeletal muscle. J Neuropathol Exp Neurol (2011) 0.85

The human aldose reductase AKR1B1 qualifies as the primary prostaglandin F synthase in the endometrium. J Clin Endocrinol Metab (2010) 0.85

Oxytocin receptor down-regulation is not necessary for reducing oxytocin-induced prostaglandin F(2alpha) accumulation by interferon-tau in a bovine endometrial epithelial cell line. Endocrinology (2008) 0.85

The effects of estrogen and progesterone on prostaglandins and integrin beta 3 (beta3) subunit expression in primary cultures of bovine endometrial cells. Domest Anim Endocrinol (2003) 0.84

Targeted Gene Addition of Microdystrophin in Mice Skeletal Muscle via Human Myoblast Transplantation. Mol Ther Nucleic Acids (2013) 0.84

The multidrug resistance-associated protein 4 (MRP4) appears as a functional carrier of prostaglandins regulated by oxytocin in the bovine endometrium. Endocrinology (2011) 0.83

Experimental and therapeutic approaches to muscular dystrophies. Curr Opin Neurol (2002) 0.83

Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice. Mol Ther (2010) 0.83

Influence of different isoforms of recombinant trophoblastic interferons on prostaglandin production in cultured bovine endometrial cells. Biol Reprod (2003) 0.83

Losartan enhances the success of myoblast transplantation. Cell Transplant (2011) 0.82

Use of repeating dispensers to increase the efficiency of the intramuscular myogenic cell injection procedure. Cell Transplant (2006) 0.82

Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease. PLoS One (2010) 0.82

Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism. Am J Transplant (2004) 0.81

Cell therapies for inherited myopathies. Curr Opin Rheumatol (2003) 0.81

Assessment of a symptomatic Duchenne muscular dystrophy carrier 20 years after myoblast transplantation from her asymptomatic identical twin sister. Neuromuscul Disord (2013) 0.81

Electroporation as a method to induce myofiber regeneration and increase the engraftment of myogenic cells in skeletal muscles of primates. J Neuropathol Exp Neurol (2013) 0.80

Expression of cyclooxygenase-2 and granulocyte-macrophage colony-stimulating factor in the endometrial epithelium of the cow is up-regulated during early pregnancy and in response to intrauterine infusions of interferon-tau. Biol Reprod (2003) 0.80

Growth factor coinjection improves the migration potential of monkey myogenic precursors without affecting cell transplantation success. Cell Transplant (2009) 0.80

Expression of human prostaglandin transporter in the human endometrium across the menstrual cycle. J Clin Endocrinol Metab (2005) 0.80

Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patients. Expert Opin Biol Ther (2015) 0.79

Intramuscular Transplantation of Muscle Precursor Cells over-expressing MMP-9 improves Transplantation Success. PLoS Curr (2011) 0.79

Abnormal prostaglandin E2 production blocks myogenic differentiation in myotonic dystrophy. Neurobiol Dis (2011) 0.79

Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector. Cell Transplant (2002) 0.79

Epidermal growth factor receptor is an obligatory intermediate for oxytocin-induced cyclooxygenase 2 expression and prostaglandin F2 alpha production in bovine endometrial epithelial cells. Endocrinology (2010) 0.79

Expression and contribution of three different isoforms of prostaglandin E synthase in the bovine endometrium. Biol Reprod (2005) 0.79

Fibrin gel improves the survival of transplanted myoblasts. Cell Transplant (2011) 0.79

Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog muscles. Hum Gene Ther (2010) 0.79

Central tolerance to myogenic cell transplants does not include muscle neoantigens. Transplantation (2008) 0.78

15-Hydroxyprostaglandin dehydrogenase in the bovine endometrium during the oestrous cycle and early pregnancy. Reproduction (2006) 0.78

Molecular cloning and tissue distribution of microsomal-1 and cytosolic prostaglandin E synthases in macaque. Prostaglandins Other Lipid Mediat (2005) 0.77

Effects of vitamin C on cytotherapy-mediated muscle regeneration. Cell Transplant (2012) 0.77

Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use. Cell Transplant (2006) 0.77

1,25-dihydroxyvitamin D3 increases the transplantation success of human muscle precursor cells in SCID mice. Cell Transplant (2007) 0.77

Independent regulation of prostaglandins and monocyte chemoattractant protein-1 by interleukin-1beta and hCG in human endometrial cells. Hum Reprod (2004) 0.77

A first semimanual device for clinical intramuscular repetitive cell injections. Cell Transplant (2010) 0.77

Ex vivo modification of cells to induce a muscle-based expression. Curr Gene Ther (2006) 0.77

Expression of microsomal prostaglandin E synthase in bovine endometrium: coexpression with cyclooxygenase type 2 and regulation by interferon-tau. Endocrinology (2002) 0.77